Target type: biologicalprocess
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ammonium stimulus. [GO_REF:0000071, GOC:TermGenie, PMID:23509267]
Cellular response to ammonium ion is a complex process that involves a tightly regulated network of cellular mechanisms to maintain ammonium homeostasis and prevent its toxic effects. Ammonium is a highly reactive molecule, and its accumulation within cells can disrupt cellular metabolism, leading to a variety of detrimental outcomes.
**1. Sensing and Transport:**
- Cells possess specific sensing mechanisms to detect fluctuations in ammonium levels. These mechanisms can be enzymatic or involve membrane-bound receptors.
- Once detected, ammonium can be transported across the cell membrane through dedicated transport proteins. These transporters can either be passive, driven by concentration gradients, or active, requiring energy input to move ammonium against its gradient.
**2. Ammonium Assimilation and Detoxification:**
- **Assimilation:** Ammonium is incorporated into organic molecules, primarily through the glutamine synthetase/glutamate synthase pathway.
- Glutamine synthetase catalyzes the conversion of glutamate and ammonium to glutamine, using ATP as an energy source.
- Glutamine serves as a nitrogen donor in various metabolic pathways, including the synthesis of amino acids, nucleotides, and other essential biomolecules.
- **Detoxification:** In many organisms, ammonium can be converted to urea, a less toxic form that is readily excreted.
- The urea cycle, a series of enzymatic reactions, converts ammonium to urea in the liver.
**3. Ammonium Regulation:**
- **Homeostasis:** Cells maintain a delicate balance of ammonium levels through intricate regulatory mechanisms.
- **Regulation of Enzyme Activity:** The activity of enzymes involved in ammonium metabolism is tightly controlled, ensuring efficient assimilation and detoxification.
- **Transcriptional Regulation:** Cells can adjust the expression of genes encoding ammonium transporters, assimilating enzymes, and detoxifying enzymes in response to changes in ammonium levels.
- **Post-translational Modification:** Ammonium can also influence the activity of proteins through post-translational modifications, such as phosphorylation, acetylation, and ubiquitination.
**4. Cellular Responses to High Ammonium Levels:**
- **Stress Responses:** High ammonium levels can trigger various stress responses in cells, including the activation of stress signaling pathways and the induction of protective mechanisms.
- **Apoptosis:** If ammonium accumulation exceeds the cell's detoxification capacity, it can induce apoptosis, a programmed cell death process.
- **Autophagy:** Autophagy is a cellular process that involves the degradation and recycling of cellular components, which can help to mitigate ammonium toxicity.
**5. Environmental Factors:**
- External factors, such as nutrient availability, pH, and temperature, can influence ammonium levels and cellular responses.
- In some cases, cells may adapt to high ammonium environments by upregulating ammonium transport and detoxification mechanisms.
In conclusion, cellular response to ammonium ion is a multifaceted process that involves a complex interplay of sensing, transport, assimilation, detoxification, and regulation mechanisms. These processes are essential for maintaining ammonium homeostasis and preventing its toxic effects on cellular function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Potassium voltage-gated channel subfamily C member 2 | A voltage-gated potassium channel KCNC2 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q96PR1] | Homo sapiens (human) |
Excitatory amino acid transporter 3 | An excitatory amino acid transporter 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43005] | Homo sapiens (human) |
Glutamate receptor 1 | A glutamate receptor 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P42261] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
aminolevulinic acid | 5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp. Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. | 4-oxo monocarboxylic acid; amino acid zwitterion; delta-amino acid | antineoplastic agent; dermatologic drug; Escherichia coli metabolite; human metabolite; mouse metabolite; photosensitizing agent; plant metabolite; prodrug; Saccharomyces cerevisiae metabolite |
5-aminovaleric acid | 5-aminopentanoic acid : A delta-amino acid comprising pentanoic acid with an amino substituent at C-5; a methylene homologue of gamma-aminobutyric acid (GABA) that is a weak GABA agonist. 5-aminovaleric acid: from red fox anal secretion; RN given refers to parent cpd | amino acid zwitterion; delta-amino acid; omega-amino fatty acid | human metabolite |
alanylalanine | alanylalanine: RN given refers to (DL)-isomer | dipeptide | |
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. | non-proteinogenic alpha-amino acid | |
N-(2-aminoethyl)-5-chloro-1-naphthalenesulfonamide | naphthalenes; sulfonic acid derivative | ||
cyclothiazide | cyclothiazide : 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted at positions 3, 5 and 6 by a 2-norbornen-5-yl group, chlorine, and a sulfonamide group, respectively. A thiazide diuretic, it has been used in the management of hypertension and oedema. cyclothiazide: inhibits the desensitization of AMPA-type receptors; structure | benzothiadiazine | antihypertensive agent; diuretic |
cysteine | cysteine; cysteine zwitterion; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | |
aspartic acid | aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. L-aspartic acid : The L-enantiomer of aspartic acid. | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter |
kainic acid | Kainic Acid: (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. | dicarboxylic acid; L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid | antinematodal drug; excitatory amino acid agonist |
glycylglycine | dipeptide; dipeptide zwitterion | human metabolite | |
glutamic acid | glutamic acid : An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2. Glutamic Acid: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
selfotel | selfotel: a N-methyl-D-aspartate (NMDA) antagonist; used to treat stroke-induced impairment | non-proteinogenic alpha-amino acid | |
leucyl-alanine | Leu-Ala : A dipeptide composed of L-leucine and L-alanine joined by a peptide linkage. | dipeptide | metabolite |
alanylproline | alanylproline: RN given refers to all (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
glycylleucine | Gly-Leu : A dipeptide composed of glycine and L-leucine joined by a peptide linkage. | dipeptide; dipeptide zwitterion | metabolite |
alanyltyrosine | Ala-Tyr : A dipeptide composed of L-alanine and L-tyrosine joined by a peptide linkage. alanyltyrosine: tyrosine source; RN given refers to (L)-isomer | dipeptide | metabolite |
glycylsarcosine | glycylsarcosine : A dipeptide obtained by formal condensation of the carboxy group of glycine with the amino group of sarcosine. | dipeptide; dipeptide zwitterion | |
sym 2081 | |||
glycylaspartic acid | glycylaspartic acid: RN given refers to (L)-isomer | dipeptide | metabolite |
histidinoalanine | histidinoalanine: cross-linking amino acid in calcified tissue collagen; RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
dihydrokainate | dicarboxylic acid | ||
jstx-3 | JSTX-3: structure in first source | N-acyl-amino acid | |
argiotoxin-636 | argiotoxin-636: from the venom of Argiope aurantia; blocks neuromuscular transmission in insects; structure in first source. | N-acyl-amino acid | |
2-amino-3-(3-(carboxymethoxy)-5-methylisoxazol-4-yl)propionic acid | 2-amino-3-(3-(carboxymethoxy)-5-methylisoxazol-4-yl)propionic acid: glutamate receptor antagonist; protects against kainic acid neurotoxicity in cultured cerebral cortex neurons | ||
5-fluorowillardiine | 3-(5-fluorouracil-1-yl)-L-alanine : An alanine derivative that is L-alanine bearing a 5-fluorouracil-1-yl substituent at position 3. A more potent and selective AMPA receptor agonist (at hGluR1 and hGluR2) than AMPA itself (Ki = 14.7, 25.1, and 1820 nM for hGluR1, hGluR2 and hGluR5 respectively). 5-fluorowillardiine: a glutamate agonist; RN given for (S)-isomer | L-alanine derivative; non-proteinogenic L-alpha-amino acid; organofluorine compound | AMPA receptor agonist |
gyki 53655 | GYKI 53655: an AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate) receptor antagonist | ||
ly 293558 | tezampanel: structure given in first source; an AMPA receptor antagonist | ||
alanylglutamic acid | alanylglutamic acid: RN given refers to (L)-isomer L-alanyl-L-glutamic acid : A dipeptide consisting of L-glutamic acid having an L-alanyl attached to its alpha-amino group | dipeptide | |
prolyl-tyrosine | Pro-Tyr : A dipeptide formed from L-proline and L-tyrosine residues. prolyl-tyrosine: structure given in first source | dipeptide | metabolite |
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | |||
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
5-bromowillardiine | 5-bromowillardiine: acts as a kainate-like agonist on chick EAA receptors expressed in Xenopus oocytes; RN given refers to (S)-isomer; RN for cpd without isomeric designation not avail 5/91 | ||
prolylglutamic acid | Pro-Glu : A dipeptide formed from L-proline and L-glutamic acid residues. | dipeptide | metabolite |
cysteinylglycine | cysteinylglycine: RN given refers to (L)-isomer; RN for cpd without isomeric designation not in Chemlne 7/13/83 L-cysteinylglycine : A dipeptide consisting of glycine having an L-cysteinyl attached to its alpha-amino group. It is an intermediate metabolite in glutathione metabolism. | dipeptide; dipeptide zwitterion | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite |
willardiine | 3-(uracil-1-yl)-L-alanine : The 3-(uracil-1-yl) derivative of L-alanine. willardiine: isolated from seeds of Acacia willariana; structure | amino acid zwitterion; L-alanine derivative; non-proteinogenic L-alpha-amino acid | |
hinokinin | hinokinin : A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 3,4-methylenedioxybenzyl group at positions 3 and 4 (the 3R,4R-diastereoisomer). hinokinin: suppresses expression of both HBsAg and HBeAg | benzodioxoles; gamma-lactone; lignan | trypanocidal drug |
3-hydroxyaspartic acid, (threo-l)-isomer | (3S)-3-hydroxy-L-aspartic acid : The (3S)-diastereomer of 3-hydroxy-L-aspartic acid. | 3-hydroxy-L-aspartic acid | metabolite |
(S)-ATPA | (S)-ATPA : A non-proteinogenic L-alpha-amino acid that is L-alanine in which one of the methyl hydrogens is replaced by a 5-tert-butyl-3-hydroxy-isooxazol-4-yl group. | isoxazoles; non-proteinogenic L-alpha-amino acid | metabolite |
aspartyl-aspartic acid | Asp-Asp : A dipeptide formed from two L-aspartic acid units. aspartyl-aspartic acid: do not confuse with cyclo(Asp-Asp) | dipeptide | Mycoplasma genitalium metabolite |
4-bromohomoibotenic acid, (rs)-isomer | |||
glycylproline | Gly-Pro : A dipeptide consisting of L-proline having a glycyl residue attached to its alpha-amino group. | dipeptide; dipeptide zwitterion | metabolite |
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline | 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline: structure given in first source; neuroprotectant for cerebral ischemia; AMPA receptor antagonist | naphthalenes; sulfonic acid derivative | |
6-cyano-7-nitroquinoxaline-2,3-dione | 6-Cyano-7-nitroquinoxaline-2,3-dione: A potent excitatory amino acid antagonist with a preference for non-NMDA iontropic receptors. It is used primarily as a research tool. | quinoxaline derivative | |
fg 9041 | FG 9041: structure given in first source | quinoxaline derivative | |
2-amino-3-phenylmethoxybutanedioic acid | aspartic acid derivative | ||
seryl-proline | Ser-Pro : A dipeptide formed from L-serine and L-proline residues. | dipeptide | metabolite |
dl-threo-beta-benzyloxyaspartate | |||
lofepramine hydrochloride | |||
phenylalanylalanine | Phe-Ala : A dipeptide formed from L-phenylalanine and L-alanine residues. phenylalanylalanine: RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
acetylalanylalanine | acetylalanylalanine: RN given refers to (D)-isomer | ||
alpha-aspartylalanine | alpha-aspartylalanine: found in pig brain Asp-Ala : A dipeptide formed from L-alpha-aspartyl and L-valine residues. | dipeptide | metabolite |
alanyltyrosine | Tyr-Ala : A dipeptide formed from L-tyrosine and L-alanine residues. | dipeptide | metabolite |
prolylglycine | L-prolylglycine : A dipeptide consisting of glycine having an L-prolyl group attached to its alpha-amino nitrogen. prolylglycine: RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | |
cx 614 | 2H,3H,6aH-pyrrolidino(2'',1''-3',2')1,3-oxazino(6',5'-5,4)benzo(e)1, 4-dioxan-10-one: an ampakine (AMPA receptor modulator); structure in first source | ||
glutamylalanine | Glu-Ala : A dipeptide formed from L-alpha-glutamyl and L-alanine residues. | dipeptide | metabolite |
phenylalanylphenylalanine | Phe-Phe : A dipeptide formed from two L-phenylalanine residues. | dipeptide; L-aminoacyl-L-amino acid zwitterion | human blood serum metabolite; Mycoplasma genitalium metabolite |
phenylalanyl-valine | Val-Phe : A dipeptide formed from L-valine and L-phenylalanine residues. | dipeptide | metabolite |
alanylglycine | dipeptide; dipeptide zwitterion | metabolite | |
valyltyrosine | Val-Tyr : A dipeptide formed from L-valine and L-tyrosine residues. valyltyrosine: from sardine muscle hydrolyzate | dipeptide | metabolite |
phenylalanylproline | Phe-Pro : A dipeptide formed from L-phenylalanine and L-proline residues. | dipeptide | metabolite |
glycylhistidine | Gly-His : A dipeptide composed of glycine and L-histidine joined by a peptide linkage. glycylhistidine: RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
prolyl-serine | Pro-Ser : A dipeptide formed from L-proline and L-serine residues. | dipeptide | metabolite |
prolylvaline | Val-Pro : A dipeptide formed from L-valine and L-proline residues. | dipeptide | metabolite |
tqx 173 | |||
perampanel | perampanel : A member of the class of bipyridines that is 2,3'-bipyridin-6'-one substituted at positions 1' and 5' by phenyl and 2-cyanophenyl groups respectively. Used as an adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy. | bipyridines; nitrile; pyridone | AMPA receptor antagonist; anticonvulsant |
ly 404187 | LY 404187: structure in first source | ||
l-beta-threo-benzyl-aspartate | L-beta-threo-benzyl-aspartate: structure in first source | ||
ucph 101 | 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile: structure in first source |